<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Front Psychiatry</journal-id>
      <journal-id journal-id-type="iso-abbrev">Front Psychiatry</journal-id>
      <journal-id journal-id-type="publisher-id">Front. Psychiatry</journal-id>
      <journal-title-group>
        <journal-title>Frontiers in Psychiatry</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1664-0640</issn>
      <publisher>
        <publisher-name>Frontiers Media S.A.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">28751869</article-id>
      <article-id pub-id-type="pmc">5507945</article-id>
      <article-id pub-id-type="doi">10.3389/fpsyt.2017.00126</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Psychiatry</subject>
          <subj-group>
            <subject>Perspective</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Alterations of Growth Factors in Autism and Attention-Deficit/Hyperactivity Disorder</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Galvez-Contreras</surname>
            <given-names>Alma Y.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">*</xref>
          <uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/436155"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Campos-Ordonez</surname>
            <given-names>Tania</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/297798"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gonzalez-Castaneda</surname>
            <given-names>Rocio E.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/317308"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gonzalez-Perez</surname>
            <given-names>Oscar</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
          <xref ref-type="aff" rid="aff5">
            <sup>5</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/65513"/>
        </contrib>
      </contrib-group>
      <aff id="aff1"><sup>1</sup><institution>Department of Neuroscience, Institute of Translational Neuroscience, Centro Universitario de Ciencias de la Salud, University of Guadalajara</institution>, <addr-line>Guadalajara</addr-line>, <country>Mexico</country></aff>
      <aff id="aff2"><sup>2</sup><institution>Unidad de Atencion en Neurosciencias, Department of Neuroscience, Centro Universitario de Ciencias de la Salud, University of Guadalajara</institution>, <addr-line>Guadalajara</addr-line>, <country>Mexico</country></aff>
      <aff id="aff3"><sup>3</sup><institution>Laboratory of Neuroscience, School of Psychology, University of Colima</institution>, <addr-line>Colima</addr-line>, <country>Mexico</country></aff>
      <aff id="aff4"><sup>4</sup><institution>Medical Science PhD Program, School of Medicine, University of Colima</institution>, <addr-line>Colima</addr-line>, <country>Mexico</country></aff>
      <aff id="aff5"><sup>5</sup><institution>El Colegio de Colima</institution>, <addr-line>Colima</addr-line>, <country>Mexico</country></aff>
      <author-notes>
        <fn fn-type="edited-by">
          <p>Edited by: Hanna E. Stevens, University of Iowa, United States</p>
        </fn>
        <fn fn-type="edited-by">
          <p>Reviewed by: Didem Oztop, Erciyes University, Turkey; Karen M. Smith, University of Louisiana at Lafayette, United States</p>
        </fn>
        <corresp content-type="corresp" id="cor1">*Correspondence: Alma Y. Galvez-Contreras, <email>alma.galvez@academicos.udg.mx</email></corresp>
        <fn fn-type="other" id="fn001">
          <p>Specialty section: This article was submitted to Child and Adolescent Psychiatry, a section of the journal Frontiers in Psychiatry</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>13</day>
        <month>7</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2017</year>
      </pub-date>
      <volume>8</volume>
      <elocation-id>126</elocation-id>
      <history>
        <date date-type="received">
          <day>02</day>
          <month>5</month>
          <year>2017</year>
        </date>
        <date date-type="accepted">
          <day>29</day>
          <month>6</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2017 Galvez-Contreras, Campos-Ordonez, Gonzalez-Castaneda and Gonzalez-Perez.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <copyright-holder>Galvez-Contreras, Campos-Ordonez, Gonzalez-Castaneda and Gonzalez-Perez</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Growth factors (GFs) are cytokines that regulate the neural development. Recent evidence indicates that alterations in the expression level of GFs during embryogenesis are linked to the pathophysiology and clinical manifestations of attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorders (ASD). In this concise review, we summarize the current evidence that supports the role of brain-derived neurotrophic factor, insulin-like growth factor 2, hepatocyte growth factor (HGF), glial-derived neurotrophic factor, nerve growth factor, neurotrophins 3 and 4, and epidermal growth factor in the pathogenesis of ADHD and ASD. We also highlight the potential use of these GFs as clinical markers for diagnosis and prognosis of these neurodevelopmental disorders.</p>
      </abstract>
      <kwd-group>
        <kwd>biomarker</kwd>
        <kwd>developmental disorders</kwd>
        <kwd>autism spectrum disorder</kwd>
        <kwd>attention-deficit/hyperactivity disorder</kwd>
        <kwd>growth factors</kwd>
        <kwd>cytokines</kwd>
        <kwd>cerebral cortex</kwd>
        <kwd>cognitive impairment</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source id="cn01">Consejo Nacional de Ciencia y Tecnolog&#xED;a<named-content content-type="fundref-id">10.13039/501100003141</named-content></funding-source>
          <award-id rid="cn01">PN 2015-01-465, INFR280414, Red Tem&#xE1;tica C&#xE9;lulas Troncales y Medicina Regenerativa No. 271609, and Fellowship grant No. 736339</award-id>
        </award-group>
      </funding-group>
      <counts>
        <fig-count count="1"/>
        <table-count count="1"/>
        <equation-count count="0"/>
        <ref-count count="86"/>
        <page-count count="8"/>
        <word-count count="6188"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="introduction" id="S1">
      <title>Introduction</title>
      <p>During neural development, a myriad of biological events occurs simultaneously, i.e., neurogenesis, gliogenesis, cellular migration, cell differentiation, synapse formation, etc. These neurobiological processes are orchestrated by several growth factors (GFs) and help shape the postnatal brain (<xref rid="B1" ref-type="bibr">1</xref>). In the postnatal brain, GFs have been extensively studied and most of them share similar cell functions to those reported in the neurodevelopment (<xref rid="B2" ref-type="bibr">2</xref>&#x2013;<xref rid="B4" ref-type="bibr">4</xref>). Increasing evidence indicates that GFs modulate motor, emotional, and cognitive functions, which may explain several clinical manifestations of psychiatric disorders (<xref rid="B5" ref-type="bibr">5</xref>).</p>
      <p>Neurodevelopmental disorders comprise a group of neurological conditions that are considered a public health problem with strong socioeconomic impact (<xref rid="B6" ref-type="bibr">6</xref>). These disorders have a very complex etiology and are characterized by early-onset during childhood. The initial pathological change appears to involve abnormal growth-factor expression during embryogenesis, which persist in the adulthood and may contribute to some clinical manifestations (<xref rid="B6" ref-type="bibr">6</xref>).</p>
      <p>Some of the most common neurodevelopment disorders are autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD). These disorders generate a poor global performance throughout life. ADHD and ASD have a complex etiology and their pathophysiology remains unclear. ADHD and ASD are often comorbid disorders (<xref rid="B7" ref-type="bibr">7</xref>) that share some morphological, molecular, and functional characteristics, such as: abnormal growth of neural tissue (<xref rid="B8" ref-type="bibr">8</xref>), cognitive impairment (<xref rid="B9" ref-type="bibr">9</xref>), male preponderance, epigenetic components (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B10" ref-type="bibr">10</xref>), and abnormal expression levels of GFs in serum and brain. Remarkably, the expression level of some growth-factor correlates with the clinical manifestations of ADHD and ASD (<xref rid="B11" ref-type="bibr">11</xref>). This evidence suggests the role of GFs in the pathophysiology of these disorders. Herein, we summarize the current evidence obtained in humans and animal models that associate GFs levels with ADHD and ASD (Table <xref ref-type="table" rid="T1">1</xref>). This correlation unveils the attractive possibility to use GFs as serological biomarkers to establish diagnosis and prognosis for these disorders.</p>
      <table-wrap id="T1" position="float">
        <label>Table 1</label>
        <caption>
          <p>Relationship between growth-factor levels and clinical symptoms in neurodevelopmental disorders.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th valign="top" align="left" rowspan="1" colspan="1">Neurodevelopment disorder</th>
              <th valign="top" align="left" rowspan="1" colspan="1">Growth factor</th>
              <th valign="top" align="left" rowspan="1" colspan="1">Population/animal model</th>
              <th valign="top" align="left" rowspan="1" colspan="1">Biological sample analyzed</th>
              <th valign="top" align="left" rowspan="1" colspan="1">Related symptoms</th>
              <th valign="top" align="left" rowspan="1" colspan="1">Genetic polymorphism</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" valign="top" rowspan="18" colspan="1">Attention-deficit/hyperactivity disorder</td>
              <td align="left" valign="top" rowspan="5" colspan="1">Brain-derived neurotrophic factor (BDNF) &#x2193; (<xref rid="B12" ref-type="bibr">12</xref>&#x2013;<xref rid="B14" ref-type="bibr">14</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Children and adolescents (<xref rid="B14" ref-type="bibr">14</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Blood sample</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Hyperactivity (<xref rid="B15" ref-type="bibr">15</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">BDNF (rs10835210 and rs11030101) (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Adult (<xref rid="B12" ref-type="bibr">12</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Blood sample</td>
              <td align="left" valign="top" rowspan="4" colspan="1">Impairment of spatial learning (<xref rid="B13" ref-type="bibr">13</xref>)</td>
              <td align="left" valign="top" rowspan="4" colspan="1">BDNF (rs6265/Val) (<xref rid="B18" ref-type="bibr">18</xref>)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Adult male spontaneous hypertensive rats (SHR) (<xref rid="B13" ref-type="bibr">13</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Hippocampus (<xref rid="B13" ref-type="bibr">13</xref>)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">BDNF<sup>2lox/2lox</sup>/93 mice (<xref rid="B19" ref-type="bibr">19</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Hippocampus, hypothalamus, and cortex (<xref rid="B19" ref-type="bibr">19</xref>)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Dopamine transporter knockout mice (DAT<sup>&#x2212;/&#x2212;</sup>) (<xref rid="B20" ref-type="bibr">20</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Frontal cortex (<xref rid="B20" ref-type="bibr">20</xref>)</td>
            </tr>
            <tr>
              <td align="left" valign="top" colspan="5" rowspan="1">
                <hr/>
              </td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Glial-derived neurotrophic factor &#x2191; (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B21" ref-type="bibr">21</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Children (<xref rid="B21" ref-type="bibr">21</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Blood sample</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Inattention, hyperactivity and impulsivity behaviors (<xref rid="B11" ref-type="bibr">11</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Undefined</td>
            </tr>
            <tr>
              <td align="left" valign="top" colspan="5" rowspan="1">
                <hr/>
              </td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="2" colspan="1">Nerve growth factor (NGF) &#x2191; (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Children and adolescents (<xref rid="B23" ref-type="bibr">23</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Blood sample</td>
              <td align="left" valign="top" rowspan="2" colspan="1">Attentional, learning and memory impairments (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B25" ref-type="bibr">25</xref>)</td>
              <td align="left" valign="top" rowspan="2" colspan="1">NGF (rs6330) (<xref rid="B24" ref-type="bibr">24</xref>)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Adult male SHR (<xref rid="B22" ref-type="bibr">22</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Blood sample</td>
            </tr>
            <tr>
              <td align="left" valign="top" colspan="5" rowspan="1">
                <hr/>
              </td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Neurotrophin-3 &#x2191; (<xref rid="B21" ref-type="bibr">21</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Children (<xref rid="B21" ref-type="bibr">21</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Blood sample</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Undefined</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Undefined</td>
            </tr>
            <tr>
              <td align="left" valign="top" colspan="5" rowspan="1">
                <hr/>
              </td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Vascular endothelial growth factor &#x2193; (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B27" ref-type="bibr">27</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Juvenile male stroke-prone spontaneously hypertensive rats (SHRSP) (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B27" ref-type="bibr">27</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Frontal cortex (<xref rid="B27" ref-type="bibr">27</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Undefined</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Undefined</td>
            </tr>
            <tr>
              <td align="left" valign="top" colspan="5" rowspan="1">
                <hr/>
              </td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Insulin-like growth factor 2 &#x2191; (<xref rid="B28" ref-type="bibr">28</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Children (<xref rid="B28" ref-type="bibr">28</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Blood sample</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Undefined</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Undefined</td>
            </tr>
            <tr>
              <td align="left" valign="top" colspan="5" rowspan="1">
                <hr/>
              </td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">FGFR1 &#x2193; (<xref rid="B29" ref-type="bibr">29</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1"><italic>Fgfr1</italic><sup>f/f;hGfapCre</sup> mice</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Dorsal telencephalon (<xref rid="B29" ref-type="bibr">29</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Spontaneous motor hyperactivity (<xref rid="B29" ref-type="bibr">29</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Undefined</td>
            </tr>
            <tr>
              <td align="left" valign="top" colspan="6" rowspan="1">
                <hr/>
              </td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="11" colspan="1">Autism spectrum disorder</td>
              <td align="left" valign="top" rowspan="1" colspan="1">TGF-&#x3B2;1 &#x2193; (<xref rid="B30" ref-type="bibr">30</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Children (<xref rid="B30" ref-type="bibr">30</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Blood sample</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Low adaptive behaviors, stereotypy, irritability and low social interaction (<xref rid="B30" ref-type="bibr">30</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Undefined</td>
            </tr>
            <tr>
              <td align="left" valign="top" colspan="5" rowspan="1">
                <hr/>
              </td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="2" colspan="1">Epidermal growth factor &#x2193; (<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B32" ref-type="bibr">32</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Adult (<xref rid="B31" ref-type="bibr">31</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Blood sample</td>
              <td align="left" valign="top" rowspan="2" colspan="1">Hyperactivity, deficit in gross motor skills, tendency for tip toeing (<xref rid="B32" ref-type="bibr">32</xref>)</td>
              <td align="left" valign="top" rowspan="2" colspan="1">Undefined</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Children (<xref rid="B32" ref-type="bibr">32</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Blood sample</td>
            </tr>
            <tr>
              <td align="left" valign="top" colspan="5" rowspan="1">
                <hr/>
              </td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="2" colspan="1">BDNF &#x2191; (<xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B34" ref-type="bibr">34</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Valproic acid (VPA)-treated rat offspring (<xref rid="B33" ref-type="bibr">33</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Hippocampus (<xref rid="B33" ref-type="bibr">33</xref>)</td>
              <td align="left" valign="top" rowspan="2" colspan="1">Undefined</td>
              <td align="left" valign="top" rowspan="2" colspan="1">Undefined</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Children (<xref rid="B34" ref-type="bibr">34</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Blood sample</td>
            </tr>
            <tr>
              <td align="left" valign="top" colspan="5" rowspan="1">
                <hr/>
              </td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Neurotrophin-4 &#x2193; (<xref rid="B35" ref-type="bibr">35</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Children (<xref rid="B35" ref-type="bibr">35</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Blood sample</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Undefined</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Undefined</td>
            </tr>
            <tr>
              <td align="left" valign="top" colspan="5" rowspan="1">
                <hr/>
              </td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Hepatocyte growth factor &#x2193; (<xref rid="B36" ref-type="bibr">36</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Children (<xref rid="B36" ref-type="bibr">36</xref>)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Blood sample</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Undefined</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Undefined</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p><italic>Arrows represent the level variation: increased expression (upward position) and reduced expression (downward position)</italic>.</p>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec id="S2">
      <title>Attention-Deficit/Hyperactivity Disorder</title>
      <p>The ADHD has the highest incidence rate among all neurodevelopmental disorders (<xref rid="B37" ref-type="bibr">37</xref>). ADHD is characterized by inappropriate levels of inattention, hyperactivity, and impulsivity (<xref rid="B15" ref-type="bibr">15</xref>). These patients have evident social and academic problems that affect their global performance (<xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B39" ref-type="bibr">39</xref>). During the childhood, the main manifestation of ADHD is hyperactivity, which is commonly identified at the preschool, whereas inattention becomes more evident at elementary school (<xref rid="B7" ref-type="bibr">7</xref>). Children with ADHD also present negative emotionality, high emotional lability, and poor emotion management (<xref rid="B39" ref-type="bibr">39</xref>). During adolescence, patients with ADHD have high risk to suffer motor vehicle accidents, spontaneous sexual encounters, sexual diseases, unwanted pregnancies, drug abuse, poor social relationship, legal problems, etc. (<xref rid="B37" ref-type="bibr">37</xref>). Some of these ADHD symptoms persist until adulthood (<xref rid="B37" ref-type="bibr">37</xref>). In adults, ADHD induces a predisposition toward deficient relationships, substandard job performance, low socioeconomic status, and poor quality of life (<xref rid="B37" ref-type="bibr">37</xref>). ADHD is highly comorbid with other psychiatric or neurodevelopment disorders, such as oppositional defiant disorder, major depressive disorder, and anxiety disorders (<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B40" ref-type="bibr">40</xref>).</p>
      <p>Catecholamine dysfunction is the main hypothesis to explain ADHD pathophysiology; specifically, the dysfunction in dopamine receptors D4, D5, and in dopamine transporter proteins (<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B41" ref-type="bibr">41</xref>) in prefrontal cortex, nucleus accumbens, striatum, substantial nigra, ventral tegmentum, and frontal cortex (<xref rid="B6" ref-type="bibr">6</xref>). The homeostasis of dopamine system requires the brain-derived neurotrophic factor (BDNF), a widely expressed neurotrophin in brain cortex and hippocampus (<xref rid="B42" ref-type="bibr">42</xref>). BDNF is critical in the synthesis, release, and uptake of dopamine in nigro-striatal dopaminergic neurons (<xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B44" ref-type="bibr">44</xref>) and plays a fundamental role in neuronal survival, plasticity, and proliferation (<xref rid="B12" ref-type="bibr">12</xref>). During development, BDNF and its receptors TrkB not only promote survival and differentiation of neurons but also are involved in neural plasticity in adulthood (<xref rid="B13" ref-type="bibr">13</xref>). Alteration in BDNF/TrkB activity is implicated in midbrain dopaminergic dysfunction reported in ADHD, which may explain the development of the main symptoms (<xref rid="B45" ref-type="bibr">45</xref>). Low serum levels of BDNF in ADHD can persist until adulthood (<xref rid="B12" ref-type="bibr">12</xref>). This indicates that BDNF signaling alteration occurs across life spam in patients with ADHD.</p>
      <p>Polymorphisms rs11030101 and rs10835210 have been associated with a high risk to develop ADHD (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>). Some BDNF polymorphism are related to gender. The BDNF polymorphism rs6265/Val is more frequent in women with ADHD (<xref rid="B18" ref-type="bibr">18</xref>). This polymorphism has also been associated with susceptibility to neuroticism and anxiety (<xref rid="B46" ref-type="bibr">46</xref>), which may explain some psychiatry comorbid disorders. Conditional BDNF mice (BDNF<sup>2lox/2lox</sup>/93), characterized by low BDNF expression in the hippocampus, hypothalamus, and cortex, develop hyperactivity and aggression after stress (<xref rid="B19" ref-type="bibr">19</xref>), which supports the role of BDNF in the processing of motor control or in the worsening of hyperactivity symptoms of ADHD.</p>
      <p>The role of BDNF in ADHD pathophysiology is not fully understood, but the evidence in animal research provides clues to understand the biochemical mechanism that underlie this condition. These patients show several alterations in cognitive process and memory performance (<xref rid="B47" ref-type="bibr">47</xref>) that may be due to hypoactivation of prefrontal cortex (<xref rid="B48" ref-type="bibr">48</xref>). In the spontaneous hypertensive rats, an animal model for ADHD, have been found low levels of BDNF and TrkB in the hippocampus that were related to memory impairment (<xref rid="B13" ref-type="bibr">13</xref>). These findings suggest that cognitive manifestations of ADHD might be associated with alterations in BDNF signaling. In dopamine transporter knockout mice (DAT<sup>&#x2212;/&#x2212;</sup>), another animal model for ADHD, low expression level of BDNF mRNA and TrkB receptors were found in frontal cortex (<xref rid="B20" ref-type="bibr">20</xref>). BDNF regulates two crucial circuits, the fronto-striatal-cerebellar and the ventral striatal-limbic circuits in normal brain (<xref rid="B45" ref-type="bibr">45</xref>). Neural circuits in prefrontal cortex and cerebellum, which modulate the attentional process, thoughts, emotions, social behavior, and motor control, are implicated in ADHD symptomatology (<xref rid="B37" ref-type="bibr">37</xref>).</p>
      <p>Patients with ADHD show ~5% reduction in brain volume (<xref rid="B15" ref-type="bibr">15</xref>) in several regions, such as corpus callosum, orbitofrontal cortex, hippocampus, amygdala, basal ganglia, temporal lobe, prefrontal cortex, caudate, and cerebellum (<xref rid="B49" ref-type="bibr">49</xref>). Low levels in BDNF expression may explain this volume reduction, as demonstrated in late-onset forebrain-specific BDNF knockout (CaMK-BDNF<sup>KO</sup>) mice (<xref rid="B50" ref-type="bibr">50</xref>). On the other hand, patients with the pure form of ADHD lack microstructural changes in white matter tracts (<xref rid="B40" ref-type="bibr">40</xref>). In this study, the authors associated these microstructural changes with the clinical manifestations of ADHD and reported that the brain volume in gray and white matter correlates to poor cognitive processing, attention and motor planning (<xref rid="B37" ref-type="bibr">37</xref>). Interestingly, BDNF-deficient (bdnf<sup>&#x2212;/&#x2212;</sup>) mice show a significant reduction in myelin proteolipid protein and myelin basic protein in the hippocampus and cortex, with a subsequent deficit in myelination (<xref rid="B15" ref-type="bibr">15</xref>). Altogether, these data support the hypothesis that the BDNF signaling pathway is associated with changes of cognitive performance and brain structure in ADHD. Several pharmacological treatments that modulate the symptoms of ADHD can also modify GFs levels. Tricyclic antidepressants and the selective serotonin reuptake inhibitors increase the levels of BDNF (<xref rid="B15" ref-type="bibr">15</xref>). Methylphenidate, the main drug prescribed for ADHD, increases the BDNF expression in the prefrontal cortex (<xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B52" ref-type="bibr">52</xref>). A 6-week administration of methylphenidate recuperates the plasma levels of BDNF in children with ADHD (<xref rid="B42" ref-type="bibr">42</xref>).</p>
      <p>Glial-derived neurotrophic factor (GDNF) is another GF-related to the pathophysiology of ADHD. GDNF is widely involved in the survival of serotonergic and dopaminergic neurons because it has neuroprotective effects against neuroinflammation and oxidative damage (<xref rid="B21" ref-type="bibr">21</xref>). Untreated children with ADHD show high plasma levels of GDNF (<xref rid="B21" ref-type="bibr">21</xref>). These high GDNF levels have a positive correlation with inattention, hyperactivity, and impulsivity behaviors (<xref rid="B11" ref-type="bibr">11</xref>), which are the main clinical manifestations of ADHD. Remarkably, psychostimulants, such as MPH, increase levels of GDNF mRNA in the hippocampus and prefrontal cortex (<xref rid="B51" ref-type="bibr">51</xref>). Furthermore, nerve growth factor (NGF) is involved in neuronal development and brain plasticity of cholinergic neurons that are important in attentional processing. Therefore, dysregulation of NGF levels have been associated with the pathophysiology of ADHD (<xref rid="B23" ref-type="bibr">23</xref>). At genetic levels, the single nucleotide polymorphism (rs6330) is associated with the risk of ADHD (<xref rid="B24" ref-type="bibr">24</xref>). High NGF levels are found in an animal model of ADHD (<xref rid="B22" ref-type="bibr">22</xref>). Interestingly, children and adolescents with ADHD show high NGF serum levels (<xref rid="B23" ref-type="bibr">23</xref>). These alterations in the pro-NGF and/or NGF levels are related to attentional, learning, and memory impairments shown by ADHD patients (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B25" ref-type="bibr">25</xref>). Neurotrophins also play a role in the pathophysiology of ADHD (<xref rid="B21" ref-type="bibr">21</xref>). Alterations in neurotrophin-3 (NTF3) expression are considered a risk factor for ADHD in childhood (<xref rid="B2" ref-type="bibr">2</xref>). Serum NTF3 levels are increased in untreated patients (<xref rid="B21" ref-type="bibr">21</xref>).</p>
      <p>Vascular endothelial growth factor (VEGF) has an important role during brain development and repair (<xref rid="B27" ref-type="bibr">27</xref>). In stroke-prone spontaneously hypertensive rats were found downregulation of VEGF (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B27" ref-type="bibr">27</xref>), VEGFR-1 (Flt-1), and VEGFR-2 (Flk-1) receptors, endothelial nitric oxide synthase and the phosphorylated Akt in frontal cortex (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B27" ref-type="bibr">27</xref>). Since alterations on VEGF signaling have been associated with degeneration of cerebral cortex, it is possible that these alterations are implicated in cerebral abnormalities of patients with ADHD (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B27" ref-type="bibr">27</xref>).</p>
      <p>Insulin-like growth factor 2 (IGF2) regulates normal development of cerebellum and hippocampus (<xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B53" ref-type="bibr">53</xref>), both of which are affected in ADHD (<xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B44" ref-type="bibr">44</xref>). Recently, IGF2 DNA methylation may be as predisposing factor to develop ADHD (<xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B54" ref-type="bibr">54</xref>, <xref rid="B55" ref-type="bibr">55</xref>). In fact, prenatal exposure to high-fat and -sugar diet promotes IGF2 DNA methylation at birth that, in turn, has been positively associated with higher ADHD symptoms (<xref rid="B28" ref-type="bibr">28</xref>). Another GF that has also been implicated in hyperactive behavior include the fibroblast growth factor. In rodents, disruption of the Fgfr1 gene in dorsal telencephalon causes spontaneous motor hyperactivity and significant reductions in specific types of cortical inhibitory neurons (<xref rid="B29" ref-type="bibr">29</xref>). In humans, the role of FGFR in the etiology of ADHD has been suggested by pathway analysis of FGFR1b and FGFR2b activation, but further study is needed to support this assertion (<xref rid="B56" ref-type="bibr">56</xref>). In summary, the development of ADHD may be influenced by the interaction of multiple molecules and concomitant epigenetic factors, but confirmatory studies are required to reveal more definitive associations.</p>
    </sec>
    <sec id="S3">
      <title>Autism Spectrum Disorder</title>
      <p>Autism spectrum disorder is a neurodevelopmental disorder (<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B57" ref-type="bibr">57</xref>) that is typically diagnosed between 2 and 6&#x2009;years of age (<xref rid="B8" ref-type="bibr">8</xref>). ASD is characterized by impaired social communication, repetitive, or stereotyped behaviors and low interest for environment stimuli (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B58" ref-type="bibr">58</xref>). Patients with ASD have maladjustment in emotional response, anxiety, impaired emotional learning, limited interest in surrounding environment, and deficit in communication and social interactions (<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B59" ref-type="bibr">59</xref>). ASD pathology has several associated symptoms that are generated by comorbid disorders. These comorbid symptoms often include: seizures, anxiety, intellectual impairment, hyperactivity, hyper or hypo- responsiveness to stimulus, sleep disruption, aggressive behavior, etc. (<xref rid="B8" ref-type="bibr">8</xref>). Consequently, ASD is considered a complex disorder with important epigenetic components (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B60" ref-type="bibr">60</xref>, <xref rid="B61" ref-type="bibr">61</xref>).</p>
      <p>Acetylation is a common feature of the neurotrophic proteins encoded by at least 18 genes dysregulated in patients with ASD (<xref rid="B62" ref-type="bibr">62</xref>, <xref rid="B63" ref-type="bibr">63</xref>). While there is some evidence of the role of immune system dysregulation in the etiology of autism (<xref rid="B64" ref-type="bibr">64</xref>), it is possible that acetylation, lysine methylation/demethylation of histones, and inflammatory mediators affect mutual signaling pathways in both the nervous system and the immune system (<xref rid="B65" ref-type="bibr">65</xref>). Increasing evidence suggests that the abnormal increase of brain cortex and minicolumnar abnormalities observed in autism are driven by excess neuronal production (<xref rid="B66" ref-type="bibr">66</xref>&#x2013;<xref rid="B68" ref-type="bibr">68</xref>). This hypothesis has been supported by neuroimaging studies (<xref rid="B69" ref-type="bibr">69</xref>&#x2013;<xref rid="B71" ref-type="bibr">71</xref>) and three-dimensional neural cultures (a cerebral organoid model) with induced pluripotent stem cells (<xref rid="B72" ref-type="bibr">72</xref>). Since GFs regulate different aspects of neural development, including brain growth, stem cell proliferation, and cell survival, this evidence supports their role in the development of ASD (<xref rid="B32" ref-type="bibr">32</xref>) and may explain the enlargement of prefrontal and temporal cortex that persists until adulthood (<xref rid="B73" ref-type="bibr">73</xref>). The hyper-functioning in certain neural circuits observed in autism may be due to this uncontrolled growth of neural connections (<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B74" ref-type="bibr">74</xref>).</p>
      <p>The brain volume is considered as clinical indicator of certain psychiatry disorder (<xref rid="B75" ref-type="bibr">75</xref>). In patients with ASD, the brain enlargement and abnormal neuronal migration have been observed in regions, such as the subependymal cell layer, the granule layer in the dentate gyrus, the cornu ammonis subfield, and the amygdala (<xref rid="B76" ref-type="bibr">76</xref>). In contrast to this abnormal migration and brain overgrowth, some authors have reported a low rate of growth in other brain areas (<xref rid="B77" ref-type="bibr">77</xref>). In the post-mortem brain of patients with ASD has been observed a significant reduction of neuronal density in layer III, the total number of neuron in layer III, V and VI, and a decrease in the volume of neurons in layers V and VI at the fusiform gyrus (<xref rid="B77" ref-type="bibr">77</xref>). Another study reported a decrease in pyramidal neuron size in the inferior frontal cortex, specifically in the Brodmann&#x2019;s areas 44 and 45, which are brain regions involved in language processing, imitation function, and sociality processing (<xref rid="B78" ref-type="bibr">78</xref>).</p>
      <p>Children with autism show low expression levels of Neurotrophin-4 (NTF4) in blood, which have been correlated to impairments in neuroplasticity (<xref rid="B35" ref-type="bibr">35</xref>). TGF-&#x3B2;1 plasma levels are also reduced in autism and have a significant correlation with the low scores obtained in adaptive behaviors, stereotypy, irritability, and low social interaction (<xref rid="B30" ref-type="bibr">30</xref>). Similar findings have been reported in juvenile mice in which the treatment with TGF-&#x3B2;1 impairs social interaction and promotes repetitive and stereotyped behaviors. Intriguingly, TGF-&#x3B2;1 overexpression has the opposite effects in adult stages (<xref rid="B79" ref-type="bibr">79</xref>).</p>
      <p>Brain-derived neurotrophic factor serum levels are significantly increased in autism (<xref rid="B34" ref-type="bibr">34</xref>). High expression of BDNF is also found in a model of autism [valproic acid (VPA)-treated rat offspring] (<xref rid="B54" ref-type="bibr">54</xref>). In addition to the high BDNF expression in hippocampus, the VPA-treated rats show low expression of p-Akt, Bcl-2, p-CaMKII, as well as a significant increase in Bax and caspase-3 expression (<xref rid="B33" ref-type="bibr">33</xref>). This evidence is consistent with that found in BTBR T+tf/J mice (another autistic mouse strain), which present a significant upregulation of BDNF expression and myelin protein, and low expression of glial fibrillary acidic protein (<xref rid="B55" ref-type="bibr">55</xref>).</p>
      <p>Another GF involved in the pathophysiology of ASD is the epidermal growth factor (EGF). EGF strongly promotes cell proliferation and differentiation <italic>via</italic> MAPK, PKC, and Akt pathways in neural progenitor cells (<xref rid="B4" ref-type="bibr">4</xref>). Recently, EGF and its receptor protein (EGFR) have been proposed as biomarkers of schizophrenia, depression, and bipolar disorder [reviewed in Ref. (<xref rid="B5" ref-type="bibr">5</xref>)]. Interestingly, adult patients with high-functioning ASD show a significant reduction in serum levels of EGF as compared with controls (<xref rid="B31" ref-type="bibr">31</xref>). Similar findings are observed in children with ASD (<xref rid="B32" ref-type="bibr">32</xref>), who present persistent low plasma levels of EGF until adulthood (<xref rid="B80" ref-type="bibr">80</xref>). Remarkably, these low plasma levels negatively correlates with the severity of hyperactivity, the deficit in gross motor skills, and the tendency for tip toeing (<xref rid="B32" ref-type="bibr">32</xref>). In addition, patients with ASD show a reduction in Akt phosphorylation, EGFR overexpression and low levels of gamma-aminobutyric acid that correlate to the severity of alterations in several language components (<xref rid="B81" ref-type="bibr">81</xref>). Elevated Akt phosphorylation has also been found in prenatal exposure to valproate, a well-known animal model of autism (<xref rid="B82" ref-type="bibr">82</xref>). These animals show a significant growth of several brain regions, a common alteration that is also observed in autistic patients. Taken together, these data strongly support the notion that EGFR/AKT pathway may play an important role in the pathophysiology of ASD.</p>
      <p>Hepatocyte growth factor (HGF) is another molecule that has been involved in the development of ASD (<xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B83" ref-type="bibr">83</xref>). Although low levels of HGF have been reported in patients with ASD, these findings could not be correlated to the severity of symptoms (<xref rid="B36" ref-type="bibr">36</xref>). HGF promotes morphogenesis and cell proliferation after binding to the c-Met receptor, a product of the MET gene (<xref rid="B84" ref-type="bibr">84</xref>). Interestingly, polymorphisms in the MET gene appear to confer an increased susceptibility to autism and this gene is included in the chromosome 7q31 that has been linked to autism susceptibility (<xref rid="B85" ref-type="bibr">85</xref>, <xref rid="B86" ref-type="bibr">86</xref>). This evidence suggests that HGF may represent an important factor in the pathogenesis of autism.</p>
    </sec>
    <sec id="S4">
      <title>Future Approaches in Neurodevelopmental Disorders</title>
      <p>Attention-deficit/hyperactivity disorder and ASD are neurodevelopmental disorders with significant comorbidity. Increasing evidence indicates that they share some pathological features and some etiological factors. Alterations in the expression level of BDNF, GDNF, NGF, NTF3, NTF4, or EGF are common features between ADHD and ASD (Figure <xref ref-type="fig" rid="F1">1</xref>). Therefore, identifying all these aspects will allow to establish the clinical use of these GFs as biomarkers in ADHD and ASD.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Hypothetical model of growth-factor expression in the human brain based on data obtained in attention-deficit/hyperactivity disorder (ADHD)/autism spectrum disorder (ASD) animal models. The table shows the blood levels of growth factors (GF) found in patients with ADHD or ASD.</p>
        </caption>
        <graphic xlink:href="fpsyt-08-00126-g001"/>
      </fig>
    </sec>
    <sec id="S5">
      <title>Author Contributions</title>
      <p>AG-C contributed in the conception idea for the article, in the manuscript writing, and in the table design. TC-O participated in the manuscript writing and in the table and the figure design. RG-C participated in the manuscript writing and in the table and figure design. OG-P contributed to the conception of the idea for the article and in the manuscript writing type.</p>
    </sec>
    <sec id="S6">
      <title>Conflict of Interest Statement</title>
      <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="financial-disclosure">
        <p><bold>Funding.</bold> This work was kindly supported by grants from Consejo Nacional de Ciencia y Tecnologia (CONACyT No. PN 2015-01-465 and INFR-280414), the Red Tem&#xE1;tica C&#xE9;lulas Troncales y Medicina Regenerativa (No. 271609), and the CONACyT&#x2019;s Fellowship grant (No. 736339).</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costales</surname><given-names>J</given-names></name><name><surname>Kolevzon</surname><given-names>A</given-names></name></person-group>
<article-title>The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders</article-title>. <source>Neurosci Biobehav Rev</source> (<year>2016</year>) <volume>63</volume>:<fpage>207</fpage>&#x2013;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1016/j.neubiorev.2016.01.001</pub-id><pub-id pub-id-type="pmid">26780584</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribases</surname><given-names>M</given-names></name><name><surname>Ramos-Quiroga</surname><given-names>JA</given-names></name><name><surname>Hervas</surname><given-names>A</given-names></name><name><surname>Bosch</surname><given-names>R</given-names></name><name><surname>Bielsa</surname><given-names>A</given-names></name><name><surname>Gastaminza</surname><given-names>X</given-names></name><etal/></person-group>
<article-title>Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB</article-title>. <source>Mol Psychiatry</source> (<year>2009</year>) <volume>14</volume>(<issue>1</issue>):<fpage>71</fpage>&#x2013;<lpage>85</lpage>.<pub-id pub-id-type="doi">10.1038/sj.mp.4002100</pub-id><pub-id pub-id-type="pmid">17938636</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galvez-Contreras</surname><given-names>AY</given-names></name><name><surname>Gonzalez-Castaneda</surname><given-names>RE</given-names></name><name><surname>Luquin</surname><given-names>S</given-names></name><name><surname>Gonzalez-Perez</surname><given-names>O</given-names></name></person-group>. <article-title>Role of fibroblast growth factor receptors in astrocytic stem cells</article-title>. <source>Curr Signal Transduct Ther</source> (<year>2012</year>) <volume>7</volume>(<issue>1</issue>):<fpage>81</fpage>&#x2013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.2174/157436212799278205</pub-id><pub-id pub-id-type="pmid">22347841</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galvez-Contreras</surname><given-names>AY</given-names></name><name><surname>Quinones-Hinojosa</surname><given-names>A</given-names></name><name><surname>Gonzalez-Perez</surname><given-names>O</given-names></name></person-group>. <article-title>The role of EGFR and ErbB family related proteins in the oligodendrocyte specification in germinal niches of the adult mammalian brain</article-title>. <source>Front Cell Neurosci</source> (<year>2013</year>) <volume>7</volume>:<fpage>258</fpage>.<pub-id pub-id-type="doi">10.3389/fncel.2013.00258</pub-id><pub-id pub-id-type="pmid">24381541</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galvez-Contreras</surname><given-names>AY</given-names></name><name><surname>Campos-Ordonez</surname><given-names>T</given-names></name><name><surname>Lopez-Virgen</surname><given-names>V</given-names></name><name><surname>Gomez-Plascencia</surname><given-names>J</given-names></name><name><surname>Ramos-Zuniga</surname><given-names>R</given-names></name><name><surname>Gonzalez-Perez</surname><given-names>O</given-names></name></person-group>
<article-title>Growth factors as clinical biomarkers of prognosis and diagnosis in psychiatric disorders</article-title>. <source>Cytokine Growth Factor Rev</source> (<year>2016</year>) <volume>32</volume>:<fpage>85</fpage>&#x2013;<lpage>96</lpage>.<pub-id pub-id-type="doi">10.1016/j.cytogfr.2016.08.004</pub-id><pub-id pub-id-type="pmid">27618303</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Homberg</surname><given-names>JR</given-names></name><name><surname>Kyzar</surname><given-names>EJ</given-names></name><name><surname>Nguyen</surname><given-names>M</given-names></name><name><surname>Norton</surname><given-names>WH</given-names></name><name><surname>Pittman</surname><given-names>J</given-names></name><name><surname>Poudel</surname><given-names>MK</given-names></name><etal/></person-group>
<article-title>Understanding autism and other neurodevelopmental disorders through experimental translational neurobehavioral models</article-title>. <source>Neurosci Biobehav Rev</source> (<year>2016</year>) <volume>65</volume>:<fpage>292</fpage>&#x2013;<lpage>312</lpage>.<pub-id pub-id-type="doi">10.1016/j.neubiorev.2016.03.013</pub-id><pub-id pub-id-type="pmid">27048961</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <mixed-citation publication-type="book"><collab>American Psychiatric Association</collab>. <source>Diagnostic and Statistical Manual of Mental Disorders DSM-V</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>American Psychiatric Association</publisher-name> (<year>2013</year>).</mixed-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pasciuto</surname><given-names>E</given-names></name><name><surname>Borrie</surname><given-names>SC</given-names></name><name><surname>Kanellopoulos</surname><given-names>AK</given-names></name><name><surname>Santos</surname><given-names>AR</given-names></name><name><surname>Cappuyns</surname><given-names>E</given-names></name><name><surname>D&#x2019;Andrea</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Autism spectrum disorders: translating human deficits into mouse behavior</article-title>. <source>Neurobiol Learn Mem</source> (<year>2015</year>) <volume>124</volume>:<fpage>71</fpage>&#x2013;<lpage>87</lpage>.<pub-id pub-id-type="doi">10.1016/j.nlm.2015.07.013</pub-id><pub-id pub-id-type="pmid">26220900</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Craig</surname><given-names>F</given-names></name><name><surname>Margari</surname><given-names>F</given-names></name><name><surname>Legrottaglie</surname><given-names>AR</given-names></name><name><surname>Palumbi</surname><given-names>R</given-names></name><name><surname>de Giambattista</surname><given-names>C</given-names></name><name><surname>Margari</surname><given-names>L</given-names></name></person-group>. <article-title>A review of executive function deficits in autism spectrum disorder and attention-deficit/hyperactivity disorder</article-title>. <source>Neuropsychiatr Dis Treat</source> (<year>2016</year>) <volume>12</volume>:<fpage>1191</fpage>&#x2013;<lpage>202</lpage>.<pub-id pub-id-type="doi">10.2147/NDT.S104620</pub-id><pub-id pub-id-type="pmid">27274255</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Visser</surname><given-names>JC</given-names></name><name><surname>Rommelse</surname><given-names>NN</given-names></name><name><surname>Greven</surname><given-names>CU</given-names></name><name><surname>Buitelaar</surname><given-names>JK</given-names></name></person-group>. <article-title>Autism spectrum disorder and attention-deficit/hyperactivity disorder in early childhood: a review of unique and shared characteristics and developmental antecedents</article-title>. <source>Neurosci Biobehav Rev</source> (<year>2016</year>) <volume>65</volume>:<fpage>229</fpage>&#x2013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1016/j.neubiorev.2016.03.019</pub-id><pub-id pub-id-type="pmid">27026637</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shim</surname><given-names>SH</given-names></name><name><surname>Hwangbo</surname><given-names>Y</given-names></name><name><surname>Yoon</surname><given-names>HJ</given-names></name><name><surname>Kwon</surname><given-names>YJ</given-names></name><name><surname>Lee</surname><given-names>HY</given-names></name><name><surname>Hwang</surname><given-names>JA</given-names></name><etal/></person-group>
<article-title>Increased levels of plasma glial-derived neurotrophic factor in children with attention deficit hyperactivity disorder</article-title>. <source>Nord J Psychiatry</source> (<year>2015</year>) <volume>69</volume>(<issue>7</issue>):<fpage>546</fpage>&#x2013;<lpage>51</lpage>.<pub-id pub-id-type="doi">10.3109/08039488.2015.1014834</pub-id><pub-id pub-id-type="pmid">25753832</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corominas-Roso</surname><given-names>M</given-names></name><name><surname>Ramos-Quiroga</surname><given-names>JA</given-names></name><name><surname>Ribases</surname><given-names>M</given-names></name><name><surname>Sanchez-Mora</surname><given-names>C</given-names></name><name><surname>Palomar</surname><given-names>G</given-names></name><name><surname>Valero</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Decreased serum levels of brain-derived neurotrophic factor in adults with attention-deficit hyperactivity disorder</article-title>. <source>Int J Neuropsychopharmacol</source> (<year>2013</year>) <volume>16</volume>(<issue>6</issue>):<fpage>1267</fpage>&#x2013;<lpage>75</lpage>.<pub-id pub-id-type="doi">10.1017/s1461145712001629</pub-id><pub-id pub-id-type="pmid">23363778</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeong</surname><given-names>HI</given-names></name><name><surname>Ji</surname><given-names>ES</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>TW</given-names></name><name><surname>Baek</surname><given-names>SB</given-names></name><name><surname>Choi</surname><given-names>SW</given-names></name></person-group>. <article-title>Treadmill exercise improves spatial learning ability by enhancing brain-derived neurotrophic factor expression in the attention-deficit/hyperactivity disorder rats</article-title>. <source>J Exerc Rehabil</source> (<year>2014</year>) <volume>10</volume>(<issue>3</issue>):<fpage>162</fpage>&#x2013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.12965/jer.140111</pub-id><pub-id pub-id-type="pmid">25061595</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeni</surname><given-names>CP</given-names></name><name><surname>Tramontina</surname><given-names>S</given-names></name><name><surname>Aguiar</surname><given-names>BW</given-names></name><name><surname>Salatino-Oliveira</surname><given-names>A</given-names></name><name><surname>Pheula</surname><given-names>GF</given-names></name><name><surname>Sharma</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>BDNF Val66Met polymorphism and peripheral protein levels in pediatric bipolar disorder and attention-deficit/hyperactivity disorder</article-title>. <source>Acta Psychiatr Scand</source> (<year>2016</year>) <volume>134</volume>(<issue>3</issue>):<fpage>268</fpage>&#x2013;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1111/acps.12587</pub-id><pub-id pub-id-type="pmid">27209073</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>SJ</given-names></name></person-group>. <article-title>Attention-deficit hyperactivity disorder and brain-derived neurotrophic factor: a speculative hypothesis</article-title>. <source>Med Hypotheses</source> (<year>2003</year>) <volume>60</volume>(<issue>6</issue>):<fpage>849</fpage>&#x2013;<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1016/S0306-9877(03)00052-5</pub-id><pub-id pub-id-type="pmid">12699711</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>S-C</given-names></name><name><surname>Kim</surname><given-names>H-W</given-names></name><name><surname>Kim</surname><given-names>B-N</given-names></name><name><surname>Kim</surname><given-names>J-W</given-names></name><name><surname>Shin</surname><given-names>M-S</given-names></name><name><surname>Chung</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Gender-specific association of the brain-derived neurotrophic factor gene with attention-deficit/hyperactivity disorder</article-title>. <source>Psychiatry Investig</source> (<year>2010</year>) <volume>7</volume>(<issue>4</issue>):<fpage>285</fpage>&#x2013;<lpage>90</lpage>.<pub-id pub-id-type="doi">10.4306/pi.2010.7.4.285</pub-id><pub-id pub-id-type="pmid">21253413</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>HJ</given-names></name><name><surname>Ha</surname><given-names>M</given-names></name><name><surname>Jin</surname><given-names>HJ</given-names></name><name><surname>Hyun</surname><given-names>JK</given-names></name><name><surname>Shim</surname><given-names>SH</given-names></name><name><surname>Paik</surname><given-names>KC</given-names></name><etal/></person-group>
<article-title>Association between BDNF gene polymorphisms and attention deficit hyperactivity disorder in Korean children</article-title>. <source>Genet Test Mol Biomarkers</source> (<year>2015</year>) <volume>19</volume>(<issue>7</issue>):<fpage>366</fpage>&#x2013;<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1089/gtmb.2015.0029</pub-id><pub-id pub-id-type="pmid">25950609</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Ji</surname><given-names>N</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Qian</surname><given-names>Q</given-names></name><etal/></person-group>
<article-title>Sex-specific association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and plasma BDNF with attention-deficit/hyperactivity disorder in a drug-na&#xEF;ve Han Chinese sample</article-title>. <source>Psychiatry Res</source> (<year>2014</year>) <volume>217</volume>(<issue>3</issue>):<fpage>191</fpage>&#x2013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/j.psychres.2014.03.011</pub-id><pub-id pub-id-type="pmid">24713358</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rios</surname><given-names>M</given-names></name><name><surname>Fan</surname><given-names>G</given-names></name><name><surname>Fekete</surname><given-names>C</given-names></name><name><surname>Kelly</surname><given-names>J</given-names></name><name><surname>Bates</surname><given-names>B</given-names></name><name><surname>Kuehn</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity</article-title>. <source>Mol Endocrinol</source> (<year>2001</year>) <volume>15</volume>(<issue>10</issue>):<fpage>1748</fpage>&#x2013;<lpage>57</lpage>.<pub-id pub-id-type="doi">10.1210/mend.15.10.0706</pub-id><pub-id pub-id-type="pmid">11579207</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fumagalli</surname><given-names>F</given-names></name><name><surname>Racagni</surname><given-names>G</given-names></name><name><surname>Colombo</surname><given-names>E</given-names></name><name><surname>Riva</surname><given-names>MA</given-names></name></person-group>
<article-title>BDNF gene expression is reduced in the frontal cortex of dopamine transporter knockout mice</article-title>. <source>Mol Psychiatry</source> (<year>2003</year>) <volume>8</volume>(<issue>11</issue>):<fpage>898</fpage>&#x2013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/sj.mp.4001370</pub-id><pub-id pub-id-type="pmid">14593425</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilgi&#xE7;</surname><given-names>A</given-names></name><name><surname>Toker</surname><given-names>A</given-names></name><name><surname>I&#x15F;&#x131;k</surname><given-names>&#xDC;</given-names></name><name><surname>K&#x131;l&#x131;n&#xE7;</surname><given-names>&#x130;</given-names></name></person-group>
<article-title>Serum brain-derived neurotrophic factor, glial-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 levels in children with attention-deficit/hyperactivity disorder</article-title>. <source>Eur Child Adolesc Psychiatry</source> (<year>2017</year>) <volume>26</volume>(<issue>3</issue>):<fpage>355</fpage>&#x2013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1007/s00787-016-0898-2</pub-id><pub-id pub-id-type="pmid">27561780</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clemow</surname><given-names>DB</given-names></name><name><surname>Steers</surname><given-names>WD</given-names></name><name><surname>Tuttle</surname><given-names>JB</given-names></name></person-group>. <article-title>Stretch-activated signaling of nerve growth factor secretion in bladder and vascular smooth muscle cells from hypertensive and hyperactive rats</article-title>. <source>J Cell Physiol</source> (<year>2000</year>) <volume>183</volume>(<issue>3</issue>):<fpage>289</fpage>&#x2013;<lpage>300</lpage>.<pub-id pub-id-type="doi">10.1002/(SICI)1097-4652(200006)183:3&lt;289:AID-JCP1&gt;3.0.CO;2-6</pub-id><pub-id pub-id-type="pmid">10797303</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guney</surname><given-names>E</given-names></name><name><surname>Ceylan</surname><given-names>MF</given-names></name><name><surname>Kara</surname><given-names>M</given-names></name><name><surname>Tekin</surname><given-names>N</given-names></name><name><surname>Goker</surname><given-names>Z</given-names></name><name><surname>Senses Dinc</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Serum nerve growth factor (NGF) levels in children with attention deficit/hyperactivity disorder (ADHD)</article-title>. <source>Neurosci Lett</source> (<year>2014</year>) <volume>560</volume>:<fpage>107</fpage>&#x2013;<lpage>11</lpage>.<pub-id pub-id-type="doi">10.1016/j.neulet.2013.12.026</pub-id><pub-id pub-id-type="pmid">24361544</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Syed</surname><given-names>Z</given-names></name><name><surname>Dudbridge</surname><given-names>F</given-names></name><name><surname>Kent</surname><given-names>L</given-names></name></person-group>. <article-title>An investigation of the neurotrophic factor genes GDNF, NGF, and NT3 in susceptibility to ADHD</article-title>. <source>Am J Med Genet B Neuropsychiatr Genet</source> (<year>2007</year>) <volume>144B</volume>(<issue>3</issue>):<fpage>375</fpage>&#x2013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1002/ajmg.b.30459</pub-id><pub-id pub-id-type="pmid">17192954</pub-id></mixed-citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiveron</surname><given-names>C</given-names></name><name><surname>Fasulo</surname><given-names>L</given-names></name><name><surname>Capsoni</surname><given-names>S</given-names></name><name><surname>Malerba</surname><given-names>F</given-names></name><name><surname>Marinelli</surname><given-names>S</given-names></name><name><surname>Paoletti</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>ProNGF\NGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice</article-title>. <source>Cell Death Differ</source> (<year>2013</year>) <volume>20</volume>(<issue>8</issue>):<fpage>1017</fpage>&#x2013;<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1038/cdd.2013.22</pub-id><pub-id pub-id-type="pmid">23538417</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <label>26</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jesmin</surname><given-names>S</given-names></name><name><surname>Togashi</surname><given-names>H</given-names></name><name><surname>Mowa</surname><given-names>CN</given-names></name><name><surname>Ueno</surname><given-names>K</given-names></name><name><surname>Yamaguchi</surname><given-names>T</given-names></name><name><surname>Shibayama</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Characterization of regional cerebral blood flow and expression of angiogenic growth factors in the frontal cortex of juvenile male SHRSP and SHR</article-title>. <source>Brain Res</source> (<year>2004</year>) <volume>1030</volume>(<issue>2</issue>):<fpage>172</fpage>&#x2013;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1016/j.brainres.2004.10.004</pub-id><pub-id pub-id-type="pmid">15571667</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <label>27</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jesmin</surname><given-names>S</given-names></name><name><surname>Togashi</surname><given-names>H</given-names></name><name><surname>Sakuma</surname><given-names>I</given-names></name><name><surname>Mowa</surname><given-names>CN</given-names></name><name><surname>Ueno</surname><given-names>K</given-names></name><name><surname>Yamaguchi</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Gonadal hormones and frontocortical expression of vascular endothelial growth factor in male stroke-prone, spontaneously hypertensive rats, a model for attention-deficit/hyperactivity disorder</article-title>. <source>Endocrinology</source> (<year>2004</year>) <volume>145</volume>(<issue>9</issue>):<fpage>4330</fpage>&#x2013;<lpage>43</lpage>.<pub-id pub-id-type="doi">10.1210/en.2004-0487</pub-id><pub-id pub-id-type="pmid">15178644</pub-id></mixed-citation>
      </ref>
      <ref id="B28">
        <label>28</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rijlaarsdam</surname><given-names>J</given-names></name><name><surname>Cecil</surname><given-names>CAM</given-names></name><name><surname>Walton</surname><given-names>E</given-names></name><name><surname>Mesirow</surname><given-names>MSC</given-names></name><name><surname>Relton</surname><given-names>CL</given-names></name><name><surname>Gaunt</surname><given-names>TR</given-names></name><etal/></person-group>
<article-title>Prenatal unhealthy diet, insulin-like growth factor 2 gene (IGF2) methylation, and attention deficit hyperactivity disorder symptoms in youth with early-onset conduct problems</article-title>. <source>J Child Psychol Psychiatry</source> (<year>2017</year>) <volume>58</volume>(<issue>1</issue>):<fpage>19</fpage>&#x2013;<lpage>27</lpage>.<pub-id pub-id-type="doi">10.1111/jcpp.12589</pub-id><pub-id pub-id-type="pmid">27535767</pub-id></mixed-citation>
      </ref>
      <ref id="B29">
        <label>29</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>KM</given-names></name><name><surname>Fagel</surname><given-names>DM</given-names></name><name><surname>Stevens</surname><given-names>HE</given-names></name><name><surname>Rabenstein</surname><given-names>RL</given-names></name><name><surname>Maragnoli</surname><given-names>ME</given-names></name><name><surname>Ohkubo</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Deficiency in inhibitory cortical interneurons associates with hyperactivity in fibroblast growth factor receptor 1 mutant mice</article-title>. <source>Biol Psychiatry</source> (<year>2008</year>) <volume>63</volume>(<issue>10</issue>):<fpage>953</fpage>&#x2013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1016/j.biopsych.2007.09.020</pub-id><pub-id pub-id-type="pmid">17988653</pub-id></mixed-citation>
      </ref>
      <ref id="B30">
        <label>30</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashwood</surname><given-names>P</given-names></name><name><surname>Enstrom</surname><given-names>A</given-names></name><name><surname>Krakowiak</surname><given-names>P</given-names></name><name><surname>Hertz-Picciotto</surname><given-names>I</given-names></name><name><surname>Hansen</surname><given-names>R</given-names></name><name><surname>Croen</surname><given-names>LA</given-names></name><etal/></person-group>
<article-title>Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes</article-title>. <source>J Neuroimmunol</source> (<year>2008</year>) <volume>204</volume>(<issue>1&#x2013;2</issue>):<fpage>149</fpage>&#x2013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1016/j.jneuroim.2008.07.006</pub-id><pub-id pub-id-type="pmid">18762342</pub-id></mixed-citation>
      </ref>
      <ref id="B31">
        <label>31</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Hashimoto</surname><given-names>K</given-names></name><name><surname>Iwata</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Tsujii</surname><given-names>M</given-names></name><name><surname>Tsuchiya</surname><given-names>KJ</given-names></name><etal/></person-group>
<article-title>Decreased serum levels of epidermal growth factor in adult subjects with high-functioning autism</article-title>. <source>Biol Psychiatry</source> (<year>2007</year>) <volume>62</volume>(<issue>3</issue>):<fpage>267</fpage>&#x2013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.biopsych.2006.08.001</pub-id><pub-id pub-id-type="pmid">17123472</pub-id></mixed-citation>
      </ref>
      <ref id="B32">
        <label>32</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname><given-names>AJ</given-names></name></person-group>
<article-title>Decreased epidermal growth factor (EGF) associated with HMGB1 and increased hyperactivity in children with autism</article-title>. <source>Biomark Insights</source> (<year>2013</year>) <volume>8</volume>:<fpage>35</fpage>&#x2013;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.4137/BMI.S11270</pub-id><pub-id pub-id-type="pmid">23645980</pub-id></mixed-citation>
      </ref>
      <ref id="B33">
        <label>33</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Mil</surname><given-names>NH</given-names></name><name><surname>Steegers-Theunissen</surname><given-names>RPM</given-names></name><name><surname>Bouwland-Both</surname><given-names>MI</given-names></name><name><surname>Verbiest</surname><given-names>MMPJ</given-names></name><name><surname>Rijlaarsdam</surname><given-names>J</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>DNA methylation profiles at birth and child ADHD symptoms</article-title>. <source>J Psychiatr Res</source> (<year>2014</year>) <volume>49</volume>:<fpage>51</fpage>&#x2013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.jpsychires.2013.10.017</pub-id><pub-id pub-id-type="pmid">24290898</pub-id></mixed-citation>
      </ref>
      <ref id="B34">
        <label>34</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>X</given-names></name><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Cao</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Loh</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>Y</given-names></name></person-group>. <article-title>Association of peripheral blood levels of brain-derived neurotrophic factor with autism spectrum disorder in children: a systematic review and meta-analysis</article-title>. <source>JAMA Pediatr</source> (<year>2016</year>) <volume>170</volume>(<issue>11</issue>):<fpage>1079</fpage>&#x2013;<lpage>86</lpage>.<pub-id pub-id-type="doi">10.1001/jamapediatrics.2016.1626</pub-id><pub-id pub-id-type="pmid">27654278</pub-id></mixed-citation>
      </ref>
      <ref id="B35">
        <label>35</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdallah</surname><given-names>MW</given-names></name><name><surname>Mortensen</surname><given-names>EL</given-names></name><name><surname>Greaves-Lord</surname><given-names>K</given-names></name><name><surname>Larsen</surname><given-names>N</given-names></name><name><surname>Bonefeld-Jorgensen</surname><given-names>EC</given-names></name><name><surname>Norgaard-Pedersen</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Neonatal levels of neurotrophic factors and risk of autism spectrum disorders</article-title>. <source>Acta Psychiatr Scand</source> (<year>2013</year>) <volume>128</volume>(<issue>1</issue>):<fpage>61</fpage>&#x2013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1111/acps.12020</pub-id><pub-id pub-id-type="pmid">23039165</pub-id></mixed-citation>
      </ref>
      <ref id="B36">
        <label>36</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname><given-names>AJ</given-names></name></person-group>
<article-title>Correlation between hepatocyte growth factor (HGF) and gamma-aminobutyric acid (GABA) plasma levels in autistic children</article-title>. <source>Biomark Insights</source> (<year>2013</year>) <volume>8</volume>:<fpage>69</fpage>&#x2013;<lpage>75</lpage>.<pub-id pub-id-type="doi">10.4137/bmi.s11448</pub-id><pub-id pub-id-type="pmid">23825437</pub-id></mixed-citation>
      </ref>
      <ref id="B37">
        <label>37</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>A</given-names></name><name><surname>Couture</surname><given-names>J</given-names></name></person-group>. <article-title>A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD)</article-title>. <source>Ann Pharmacother</source> (<year>2014</year>) <volume>48</volume>(<issue>2</issue>):<fpage>209</fpage>&#x2013;<lpage>25</lpage>.<pub-id pub-id-type="doi">10.1177/1060028013510699</pub-id><pub-id pub-id-type="pmid">24259638</pub-id></mixed-citation>
      </ref>
      <ref id="B38">
        <label>38</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loe</surname><given-names>IM</given-names></name><name><surname>Feldman</surname><given-names>HM</given-names></name></person-group>. <article-title>Academic and educational outcomes of children with ADHD</article-title>. <source>J Pediatr Psychol</source> (<year>2007</year>) <volume>32</volume>(<issue>6</issue>):<fpage>643</fpage>&#x2013;<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1093/jpepsy/jsl054</pub-id><pub-id pub-id-type="pmid">17569716</pub-id></mixed-citation>
      </ref>
      <ref id="B39">
        <label>39</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McQuade</surname><given-names>JD</given-names></name><name><surname>Breaux</surname><given-names>RP</given-names></name></person-group>
<article-title>Are elevations in ADHD symptoms associated with physiological reactivity and emotion dysregulation in children?</article-title>
<source>J Abnorm Child Psychol</source> (<year>2016</year>):<fpage>1</fpage>&#x2013;<lpage>13</lpage>.<pub-id pub-id-type="doi">10.1007/s10802-016-0227-8</pub-id><pub-id pub-id-type="pmid">26687502</pub-id></mixed-citation>
      </ref>
      <ref id="B40">
        <label>40</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adisetiyo</surname><given-names>V</given-names></name><name><surname>Tabesh</surname><given-names>A</given-names></name><name><surname>Di Martino</surname><given-names>A</given-names></name><name><surname>Falangola</surname><given-names>MF</given-names></name><name><surname>Castellanos</surname><given-names>FX</given-names></name><name><surname>Jensen</surname><given-names>JH</given-names></name><etal/></person-group>
<article-title>Attention-deficit/hyperactivity disorder without comorbidity is associated with distinct atypical patterns of cerebral microstructural development</article-title>. <source>Hum Brain Mapp</source> (<year>2014</year>) <volume>35</volume>(<issue>5</issue>):<fpage>2148</fpage>&#x2013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1002/hbm.22317</pub-id><pub-id pub-id-type="pmid">23907808</pub-id></mixed-citation>
      </ref>
      <ref id="B41">
        <label>41</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banaschewski</surname><given-names>T</given-names></name><name><surname>Becker</surname><given-names>K</given-names></name><name><surname>Scherag</surname><given-names>S</given-names></name><name><surname>Franke</surname><given-names>B</given-names></name><name><surname>Coghill</surname><given-names>D</given-names></name></person-group>. <article-title>Molecular genetics of attention-deficit/hyperactivity disorder: an overview</article-title>. <source>Eur Child Adolesc Psychiatry</source> (<year>2010</year>) <volume>19</volume>(<issue>3</issue>):<fpage>237</fpage>&#x2013;<lpage>57</lpage>.<pub-id pub-id-type="doi">10.1007/s00787-010-0090-z</pub-id><pub-id pub-id-type="pmid">20145962</pub-id></mixed-citation>
      </ref>
      <ref id="B42">
        <label>42</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amiri</surname><given-names>A</given-names></name><name><surname>Torabi Parizi</surname><given-names>G</given-names></name><name><surname>Kousha</surname><given-names>M</given-names></name><name><surname>Saadat</surname><given-names>F</given-names></name><name><surname>Modabbernia</surname><given-names>MJ</given-names></name><name><surname>Najafi</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Changes in plasma brain-derived neurotrophic factor (BDNF) levels induced by methylphenidate in children with attention deficit-hyperactivity disorder (ADHD)</article-title>. <source>Prog Neuropsychopharmacol Biol Psychiatry</source> (<year>2013</year>) <volume>47</volume>:<fpage>20</fpage>&#x2013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1016/j.pnpbp.2013.07.018</pub-id><pub-id pub-id-type="pmid">23933054</pub-id></mixed-citation>
      </ref>
      <ref id="B43">
        <label>43</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castellanos</surname><given-names>F</given-names></name><name><surname>Lee</surname><given-names>PP</given-names></name><name><surname>Sharp</surname><given-names>W</given-names></name><name><surname>Jeffries</surname><given-names>NO</given-names></name><name><surname>Greenstein</surname><given-names>DK</given-names></name><name><surname>Clasen</surname><given-names>LS</given-names></name><etal/></person-group>
<article-title>Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder</article-title>. <source>JAMA</source> (<year>2002</year>) <volume>288</volume>(<issue>14</issue>):<fpage>1740</fpage>&#x2013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1001/jama.288.14.1740</pub-id><pub-id pub-id-type="pmid">12365958</pub-id></mixed-citation>
      </ref>
      <ref id="B44">
        <label>44</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plessen</surname><given-names>KJ</given-names></name><name><surname>Bansal</surname><given-names>R</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Whiteman</surname><given-names>R</given-names></name><name><surname>Amat</surname><given-names>J</given-names></name><name><surname>Quackenbush</surname><given-names>GA</given-names></name><etal/></person-group>
<article-title>Hippocampus and amygdala morphology in attention-deficit/hyperactivity disorder</article-title>. <source>Arch Gen Psychiatry</source> (<year>2006</year>) <volume>63</volume>(<issue>7</issue>):<fpage>795</fpage>&#x2013;<lpage>807</lpage>.<pub-id pub-id-type="doi">10.1001/archpsyc.63.7.795</pub-id><pub-id pub-id-type="pmid">16818869</pub-id></mixed-citation>
      </ref>
      <ref id="B45">
        <label>45</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>DY</given-names></name><name><surname>Shen</surname><given-names>XM</given-names></name><name><surname>Yuan</surname><given-names>FF</given-names></name><name><surname>Guo</surname><given-names>OY</given-names></name><name><surname>Zhong</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>JG</given-names></name><etal/></person-group>
<article-title>The physiology of BDNF and its relationship with ADHD</article-title>. <source>Mol Neurobiol</source> (<year>2015</year>) <volume>52</volume>(<issue>3</issue>):<fpage>1467</fpage>&#x2013;<lpage>76</lpage>.<pub-id pub-id-type="doi">10.1007/s12035-014-8956-6</pub-id><pub-id pub-id-type="pmid">25354496</pub-id></mixed-citation>
      </ref>
      <ref id="B46">
        <label>46</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gadow</surname><given-names>KD</given-names></name><name><surname>Roohi</surname><given-names>J</given-names></name><name><surname>DeVincent</surname><given-names>CJ</given-names></name><name><surname>Kirsch</surname><given-names>S</given-names></name><name><surname>Hatchwell</surname><given-names>E</given-names></name></person-group>. <article-title>Association of COMT (Val158Met) and BDNF (Val66Met) gene polymorphisms with anxiety, ADHD and tics in children with autism spectrum disorder</article-title>. <source>J Autism Dev Disord</source> (<year>2009</year>) <volume>39</volume>(<issue>11</issue>):<fpage>1542</fpage>&#x2013;<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1007/s10803-009-0794-4</pub-id><pub-id pub-id-type="pmid">19582565</pub-id></mixed-citation>
      </ref>
      <ref id="B47">
        <label>47</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattfeld</surname><given-names>AT</given-names></name><name><surname>Whitfield-Gabrieli</surname><given-names>S</given-names></name><name><surname>Biederman</surname><given-names>J</given-names></name><name><surname>Spencer</surname><given-names>T</given-names></name><name><surname>Brown</surname><given-names>A</given-names></name><name><surname>Fried</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Dissociation of working memory impairments and attention-deficit/hyperactivity disorder in the brain</article-title>. <source>Neuroimage Clin</source> (<year>2016</year>) <volume>10</volume>:<fpage>274</fpage>&#x2013;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1016/j.nicl.2015.12.003</pub-id><pub-id pub-id-type="pmid">26900567</pub-id></mixed-citation>
      </ref>
      <ref id="B48">
        <label>48</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bollmann</surname><given-names>S</given-names></name><name><surname>Ghisleni</surname><given-names>C</given-names></name><name><surname>Poil</surname><given-names>SS</given-names></name><name><surname>Martin</surname><given-names>E</given-names></name><name><surname>Ball</surname><given-names>J</given-names></name><name><surname>Eich-H&#xF6;chli</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Age-dependent and -independent changes in attention-deficit/hyperactivity disorder (ADHD) during spatial working memory performance</article-title>. <source>World J Biol Psychiatry</source> (<year>2017</year>) <volume>18</volume>(<issue>4</issue>):<fpage>279</fpage>&#x2013;<lpage>90</lpage>.<pub-id pub-id-type="doi">10.3109/15622975.2015.1112034</pub-id><pub-id pub-id-type="pmid">26515661</pub-id></mixed-citation>
      </ref>
      <ref id="B49">
        <label>49</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amico</surname><given-names>F</given-names></name><name><surname>Stauber</surname><given-names>J</given-names></name><name><surname>Koutsouleris</surname><given-names>N</given-names></name><name><surname>Frodl</surname><given-names>T</given-names></name></person-group>. <article-title>Anterior cingulate cortex gray matter abnormalities in adults with attention deficit hyperactivity disorder: a voxel-based morphometry study</article-title>. <source>Psychiatry Res</source> (<year>2011</year>) <volume>191</volume>(<issue>1</issue>):<fpage>31</fpage>&#x2013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1016/j.pscychresns.2010.08.011</pub-id><pub-id pub-id-type="pmid">21129938</pub-id></mixed-citation>
      </ref>
      <ref id="B50">
        <label>50</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ouchi</surname><given-names>Y</given-names></name><name><surname>Banno</surname><given-names>Y</given-names></name><name><surname>Shimizu</surname><given-names>Y</given-names></name><name><surname>Ando</surname><given-names>S</given-names></name><name><surname>Hasegawa</surname><given-names>H</given-names></name><name><surname>Adachi</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Reduced adult hippocampal neurogenesis and working memory deficits in the Dgcr8-deficient mouse model of 22q11.2 deletion-associated schizophrenia can be rescued by IGF2</article-title>. <source>J Neurosci</source> (<year>2013</year>) <volume>33</volume>(<issue>22</issue>):<fpage>9408</fpage>&#x2013;<lpage>19</lpage>.<pub-id pub-id-type="doi">10.1523/jneurosci.2700-12.2013</pub-id><pub-id pub-id-type="pmid">23719809</pub-id></mixed-citation>
      </ref>
      <ref id="B51">
        <label>51</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simchon-Tenenbaum</surname><given-names>Y</given-names></name><name><surname>Weizman</surname><given-names>A</given-names></name><name><surname>Rehavi</surname><given-names>M</given-names></name></person-group>. <article-title>Alterations in brain neurotrophic and glial factors following early age chronic methylphenidate and cocaine administration</article-title>. <source>Behav Brain Res</source> (<year>2015</year>) <volume>282</volume>:<fpage>125</fpage>&#x2013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbr.2014.12.058</pub-id><pub-id pub-id-type="pmid">25576963</pub-id></mixed-citation>
      </ref>
      <ref id="B52">
        <label>52</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lukkes</surname><given-names>JL</given-names></name><name><surname>Freund</surname><given-names>N</given-names></name><name><surname>Thompson</surname><given-names>BS</given-names></name><name><surname>Meda</surname><given-names>S</given-names></name><name><surname>Andersen</surname><given-names>SL</given-names></name></person-group>. <article-title>Preventative treatment in an animal model of ADHD: behavioral and biochemical effects of methylphenidate and its interactions with ovarian hormones in female rats</article-title>. <source>Eur Neuropsychopharmacol</source> (<year>2016</year>) <volume>26</volume>(<issue>9</issue>):<fpage>1496</fpage>&#x2013;<lpage>506</lpage>.<pub-id pub-id-type="doi">10.1016/j.euroneuro.2016.06.003</pub-id><pub-id pub-id-type="pmid">27397110</pub-id></mixed-citation>
      </ref>
      <ref id="B53">
        <label>53</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pidsley</surname><given-names>R</given-names></name><name><surname>Dempster</surname><given-names>E</given-names></name><name><surname>Troakes</surname><given-names>C</given-names></name><name><surname>Al-Sarraj</surname><given-names>S</given-names></name><name><surname>Mill</surname><given-names>J</given-names></name></person-group>. <article-title>Epigenetic and genetic variation at the IGF2/H19 imprinting control region on 11p15.5 is associated with cerebellum weight</article-title>. <source>Epigenetics</source> (<year>2012</year>) <volume>7</volume>(<issue>2</issue>):<fpage>155</fpage>&#x2013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.4161/epi.7.2.18910</pub-id><pub-id pub-id-type="pmid">22395465</pub-id></mixed-citation>
      </ref>
      <ref id="B54">
        <label>54</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuch</surname><given-names>V</given-names></name><name><surname>Utsumi</surname><given-names>DA</given-names></name><name><surname>Costa</surname><given-names>TVMM</given-names></name><name><surname>Kulikowski</surname><given-names>LD</given-names></name><name><surname>Muszkat</surname><given-names>M</given-names></name></person-group>
<article-title>Attention deficit hyperactivity disorder in the light of the epigenetic paradigm</article-title>. <source>Front Psychiatry</source> (<year>2015</year>) <volume>6</volume>(<issue>126</issue>):<fpage>1</fpage>&#x2013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.3389/fpsyt.2015.00126</pub-id><pub-id pub-id-type="pmid">25653621</pub-id></mixed-citation>
      </ref>
      <ref id="B55">
        <label>55</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walton</surname><given-names>E</given-names></name><name><surname>Pingault</surname><given-names>JB</given-names></name><name><surname>Cecil</surname><given-names>CAM</given-names></name><name><surname>Gaunt</surname><given-names>TR</given-names></name><name><surname>Relton</surname><given-names>CL</given-names></name><name><surname>Mill</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Epigenetic profiling of ADHD symptoms trajectories: a prospective, methylome-wide study</article-title>. <source>Mol Psychiatry</source> (<year>2017</year>) <volume>22</volume>(<issue>2</issue>):<fpage>250</fpage>&#x2013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1038/mp.2016.85</pub-id><pub-id pub-id-type="pmid">27217153</pub-id></mixed-citation>
      </ref>
      <ref id="B56">
        <label>56</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mooney</surname><given-names>MA</given-names></name><name><surname>McWeeney</surname><given-names>SK</given-names></name><name><surname>Faraone</surname><given-names>SV</given-names></name><name><surname>Hinney</surname><given-names>A</given-names></name><name><surname>Hebebrand</surname><given-names>J</given-names></name><name><surname>Consortium</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>Pathway analysis in attention deficit hyperactivity disorder: an ensemble approach</article-title>. <source>Am J Med Genet B Neuropsychiatr Genet</source> (<year>2016</year>) <volume>171</volume>(<issue>6</issue>):<fpage>815</fpage>&#x2013;<lpage>26</lpage>.<pub-id pub-id-type="doi">10.1002/ajmg.b.32446</pub-id><pub-id pub-id-type="pmid">27004716</pub-id></mixed-citation>
      </ref>
      <ref id="B57">
        <label>57</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onore</surname><given-names>C</given-names></name><name><surname>Van de Water</surname><given-names>J</given-names></name><name><surname>Ashwood</surname><given-names>P</given-names></name></person-group>. <article-title>Decreased levels of EGF in plasma of children with autism spectrum disorder</article-title>. <source>Autism Res Treat</source> (<year>2012</year>) <volume>2012</volume>:<fpage>205362</fpage>.<pub-id pub-id-type="doi">10.1155/2012/205362</pub-id><pub-id pub-id-type="pmid">22937258</pub-id></mixed-citation>
      </ref>
      <ref id="B58">
        <label>58</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bambini-Junior</surname><given-names>V</given-names></name><name><surname>Rodrigues</surname><given-names>L</given-names></name><name><surname>Behr</surname><given-names>GA</given-names></name><name><surname>Moreira</surname><given-names>JC</given-names></name><name><surname>Riesgo</surname><given-names>R</given-names></name><name><surname>Gottfried</surname><given-names>C</given-names></name></person-group>. <article-title>Animal model of autism induced by prenatal exposure to valproate: behavioral changes and liver parameters</article-title>. <source>Brain Res</source> (<year>2011</year>) <volume>1408</volume>:<fpage>8</fpage>&#x2013;<lpage>16</lpage>.<pub-id pub-id-type="doi">10.1016/j.brainres.2011.06.015</pub-id><pub-id pub-id-type="pmid">21767826</pub-id></mixed-citation>
      </ref>
      <ref id="B59">
        <label>59</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banerjee</surname><given-names>A</given-names></name><name><surname>Engineer</surname><given-names>CT</given-names></name><name><surname>Sauls</surname><given-names>BL</given-names></name><name><surname>Morales</surname><given-names>AA</given-names></name><name><surname>Kilgard</surname><given-names>MP</given-names></name><name><surname>Ploski</surname><given-names>JE</given-names></name></person-group>. <article-title>Abnormal emotional learning in a rat model of autism exposed to valproic acid in utero</article-title>. <source>Front Behav Neurosci</source> (<year>2014</year>) <volume>8</volume>:<fpage>387</fpage>.<pub-id pub-id-type="doi">10.3389/fnbeh.2014.00387</pub-id><pub-id pub-id-type="pmid">25429264</pub-id></mixed-citation>
      </ref>
      <ref id="B60">
        <label>60</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>DS</given-names></name><name><surname>Cabrera</surname><given-names>R</given-names></name><name><surname>Wallis Schultz</surname><given-names>D</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Finnell</surname><given-names>RH</given-names></name><etal/></person-group>
<article-title>Autism-like behavior and epigenetic changes associated with autism as consequences of in utero exposure to environmental pollutants in a mouse model</article-title>. <source>Behav Neurol</source> (<year>2015</year>) <volume>2015</volume>:<fpage>426263</fpage>.<pub-id pub-id-type="doi">10.1155/2015/426263</pub-id><pub-id pub-id-type="pmid">26586927</pub-id></mixed-citation>
      </ref>
      <ref id="B61">
        <label>61</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castro</surname><given-names>K</given-names></name><name><surname>Baronio</surname><given-names>D</given-names></name><name><surname>Perry</surname><given-names>IS</given-names></name><name><surname>Riesgo</surname><given-names>RDS</given-names></name><name><surname>Gottfried</surname><given-names>C</given-names></name></person-group>
<article-title>The effect of ketogenic diet in an animal model of autism induced by prenatal exposure to valproic acid</article-title>. <source>Nutr Neurosci</source> (<year>2017</year>) <volume>20</volume>(<issue>6</issue>):<fpage>343</fpage>&#x2013;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1080/1028415X.2015.1133029</pub-id><pub-id pub-id-type="pmid">26856821</pub-id></mixed-citation>
      </ref>
      <ref id="B62">
        <label>62</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>OS</given-names></name><name><surname>Varlinskaya</surname><given-names>EI</given-names></name><name><surname>Wilson</surname><given-names>CA</given-names></name><name><surname>Glatt</surname><given-names>SJ</given-names></name><name><surname>Mooney</surname><given-names>SM</given-names></name></person-group>. <article-title>Acute prenatal exposure to a moderate dose of valproic acid increases social behavior and alters gene expression in rats</article-title>. <source>Int J Dev Neurosci</source> (<year>2013</year>) <volume>31</volume>(<issue>8</issue>):<fpage>740</fpage>&#x2013;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1016/j.ijdevneu.2013.09.002</pub-id><pub-id pub-id-type="pmid">24055786</pub-id></mixed-citation>
      </ref>
      <ref id="B63">
        <label>63</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Rubeis</surname><given-names>S</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Goldberg</surname><given-names>AP</given-names></name><name><surname>Poultney</surname><given-names>CS</given-names></name><name><surname>Samocha</surname><given-names>K</given-names></name><name><surname>Ercument Cicek</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Synaptic, transcriptional and chromatin genes disrupted in autism</article-title>. <source>Nature</source> (<year>2014</year>) <volume>515</volume>(<issue>7526</issue>):<fpage>209</fpage>&#x2013;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1038/nature13772</pub-id><pub-id pub-id-type="pmid">25363760</pub-id></mixed-citation>
      </ref>
      <ref id="B64">
        <label>64</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meltzer</surname><given-names>A</given-names></name><name><surname>Van de Water</surname><given-names>J</given-names></name></person-group>. <article-title>The role of the immune system in autism spectrum disorder</article-title>. <source>Neuropsychopharmacology</source> (<year>2017</year>) <volume>42</volume>(<issue>1</issue>):<fpage>284</fpage>&#x2013;<lpage>98</lpage>.<pub-id pub-id-type="doi">10.1038/npp.2016.158</pub-id><pub-id pub-id-type="pmid">27534269</pub-id></mixed-citation>
      </ref>
      <ref id="B65">
        <label>65</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Perez</surname><given-names>O</given-names></name><name><surname>Gutierrez-Fernandez</surname><given-names>F</given-names></name><name><surname>Lopez-Virgen</surname><given-names>V</given-names></name><name><surname>Collas-Aguilar</surname><given-names>J</given-names></name><name><surname>Quinones-Hinojosa</surname><given-names>A</given-names></name><name><surname>Garcia-Verdugo</surname><given-names>JM</given-names></name></person-group>. <article-title>Immunological regulation of neurogenic niches in the adult brain</article-title>. <source>Neuroscience</source> (<year>2012</year>) <volume>226</volume>:<fpage>270</fpage>&#x2013;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1016/j.neuroscience.2012.08.053</pub-id><pub-id pub-id-type="pmid">22986164</pub-id></mixed-citation>
      </ref>
      <ref id="B66">
        <label>66</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casanova</surname><given-names>MF</given-names></name><name><surname>Buxhoeveden</surname><given-names>DP</given-names></name><name><surname>Switala</surname><given-names>AE</given-names></name><name><surname>Roy</surname><given-names>E</given-names></name></person-group>. <article-title>Minicolumnar pathology in autism</article-title>. <source>Neurology</source> (<year>2002</year>) <volume>58</volume>(<issue>3</issue>):<fpage>428</fpage>&#x2013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1212/WNL.58.3.428</pub-id><pub-id pub-id-type="pmid">11839843</pub-id></mixed-citation>
      </ref>
      <ref id="B67">
        <label>67</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casanova</surname><given-names>MF</given-names></name><name><surname>van Kooten</surname><given-names>IAJ</given-names></name><name><surname>Switala</surname><given-names>AE</given-names></name><name><surname>van Engeland</surname><given-names>H</given-names></name><name><surname>Heinsen</surname><given-names>H</given-names></name><name><surname>Steinbusch</surname><given-names>HWM</given-names></name><etal/></person-group>
<article-title>Minicolumnar abnormalities in autism</article-title>. <source>Acta Neuropathol</source> (<year>2006</year>) <volume>112</volume>(<issue>3</issue>):<fpage>287</fpage>.<pub-id pub-id-type="doi">10.1007/s00401-006-0085-5</pub-id><pub-id pub-id-type="pmid">16819561</pub-id></mixed-citation>
      </ref>
      <ref id="B68">
        <label>68</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaushik</surname><given-names>G</given-names></name><name><surname>Zarbalis</surname><given-names>KS</given-names></name></person-group>
<article-title>Prenatal neurogenesis in autism spectrum disorders</article-title>. <source>Front Chem</source> (<year>2016</year>) <volume>4</volume>(<issue>12</issue>):<fpage>1</fpage>&#x2013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.3389/fchem.2016.00012</pub-id><pub-id pub-id-type="pmid">26835446</pub-id></mixed-citation>
      </ref>
      <ref id="B69">
        <label>69</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hazlett</surname><given-names>H</given-names></name><name><surname>Poe</surname><given-names>M</given-names></name><name><surname>Gerig</surname><given-names>G</given-names></name></person-group>
<article-title>Magnetic resonance imaging and head circumference study of brain size in autism: birth through age 2 years</article-title>. <source>Arch Gen Psychiatry</source> (<year>2005</year>) <volume>62</volume>(<issue>12</issue>):<fpage>1366</fpage>&#x2013;<lpage>76</lpage>.<pub-id pub-id-type="doi">10.1001/archpsyc.62.12.1366</pub-id><pub-id pub-id-type="pmid">16330725</pub-id></mixed-citation>
      </ref>
      <ref id="B70">
        <label>70</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Courchesne</surname><given-names>E</given-names></name><name><surname>Campbell</surname><given-names>K</given-names></name><name><surname>Solso</surname><given-names>S</given-names></name></person-group>. <article-title>Brain growth across the life span in autism: age-specific changes in anatomical pathology</article-title>. <source>Brain Res</source> (<year>2011</year>) <volume>1380</volume>:<fpage>138</fpage>&#x2013;<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1016/j.brainres.2010.09.101</pub-id><pub-id pub-id-type="pmid">20920490</pub-id></mixed-citation>
      </ref>
      <ref id="B71">
        <label>71</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lange</surname><given-names>N</given-names></name><name><surname>Travers</surname><given-names>BG</given-names></name><name><surname>Bigler</surname><given-names>ED</given-names></name><name><surname>Prigge</surname><given-names>MBD</given-names></name><name><surname>Froehlich</surname><given-names>AL</given-names></name><name><surname>Nielsen</surname><given-names>JA</given-names></name><etal/></person-group>
<article-title>Longitudinal volumetric brain changes in autism spectrum disorder ages 6&#x2013;35 years</article-title>. <source>Autism Res</source> (<year>2015</year>) <volume>8</volume>(<issue>1</issue>):<fpage>82</fpage>&#x2013;<lpage>93</lpage>.<pub-id pub-id-type="doi">10.1002/aur.1427</pub-id><pub-id pub-id-type="pmid">25381736</pub-id></mixed-citation>
      </ref>
      <ref id="B72">
        <label>72</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mariani</surname><given-names>J</given-names></name><name><surname>Coppola</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Abyzov</surname><given-names>A</given-names></name><name><surname>Provini</surname><given-names>L</given-names></name><name><surname>Tomasini</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>FOXG1-dependent dysregulation of GABA/glutamate neuron differentiation in autism spectrum disorders</article-title>. <source>Cell</source> (<year>2015</year>) <volume>162</volume>(<issue>2</issue>):<fpage>375</fpage>&#x2013;<lpage>90</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2015.06.034</pub-id><pub-id pub-id-type="pmid">26186191</pub-id></mixed-citation>
      </ref>
      <ref id="B73">
        <label>73</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ha</surname><given-names>S</given-names></name><name><surname>Sohn</surname><given-names>I-J</given-names></name><name><surname>Kim</surname><given-names>N</given-names></name><name><surname>Sim</surname><given-names>HJ</given-names></name><name><surname>Cheon</surname><given-names>K-A</given-names></name></person-group>. <article-title>Characteristics of brains in autism spectrum disorder: structure, function and connectivity across the lifespan</article-title>. <source>Exp Neurobiol</source> (<year>2015</year>) <volume>24</volume>(<issue>4</issue>):<fpage>273</fpage>&#x2013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.5607/en.2015.24.4.273</pub-id><pub-id pub-id-type="pmid">26713076</pub-id></mixed-citation>
      </ref>
      <ref id="B74">
        <label>74</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chomiak</surname><given-names>T</given-names></name><name><surname>Turner</surname><given-names>N</given-names></name><name><surname>Hu</surname><given-names>B</given-names></name></person-group>. <article-title>What we have learned about autism spectrum disorder from valproic acid</article-title>. <source>Patholog Res Int</source> (<year>2013</year>) <volume>2013</volume>:<fpage>712758</fpage>.<pub-id pub-id-type="doi">10.1155/2013/712758</pub-id><pub-id pub-id-type="pmid">24381784</pub-id></mixed-citation>
      </ref>
      <ref id="B75">
        <label>75</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevens</surname><given-names>MC</given-names></name><name><surname>Haney-Caron</surname><given-names>E</given-names></name></person-group>
<article-title>Comparison of brain volume abnormalities between ADHD and conduct disorder in adolescence</article-title>. <source>J Psychiatry Neurosci</source> (<year>2012</year>) <volume>37</volume>(<issue>6</issue>):<fpage>389</fpage>&#x2013;<lpage>98</lpage>.<pub-id pub-id-type="doi">10.1503/jpn.110148</pub-id><pub-id pub-id-type="pmid">22663946</pub-id></mixed-citation>
      </ref>
      <ref id="B76">
        <label>76</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wegiel</surname><given-names>J</given-names></name><name><surname>Kuchna</surname><given-names>I</given-names></name><name><surname>Nowicki</surname><given-names>K</given-names></name><name><surname>Imaki</surname><given-names>H</given-names></name><name><surname>Marchi</surname><given-names>E</given-names></name><name><surname>Ma</surname><given-names>SY</given-names></name><etal/></person-group>
<article-title>The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes</article-title>. <source>Acta Neuropathol</source> (<year>2010</year>) <volume>119</volume>(<issue>6</issue>):<fpage>755</fpage>&#x2013;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1007/s00401-010-0655-4</pub-id><pub-id pub-id-type="pmid">20198484</pub-id></mixed-citation>
      </ref>
      <ref id="B77">
        <label>77</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Kooten</surname><given-names>IAJ</given-names></name><name><surname>Palmen</surname><given-names>SJMC</given-names></name><name><surname>von Cappeln</surname><given-names>P</given-names></name><name><surname>Steinbusch</surname><given-names>HWM</given-names></name><name><surname>Korr</surname><given-names>H</given-names></name><name><surname>Heinsen</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Neurons in the fusiform gyrus are fewer and smaller in autism</article-title>. <source>Brain</source> (<year>2008</year>) <volume>131</volume>(<issue>4</issue>):<fpage>987</fpage>&#x2013;<lpage>99</lpage>.<pub-id pub-id-type="doi">10.1093/brain/awn033</pub-id><pub-id pub-id-type="pmid">18332073</pub-id></mixed-citation>
      </ref>
      <ref id="B78">
        <label>78</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacot-Descombes</surname><given-names>S</given-names></name><name><surname>Uppal</surname><given-names>N</given-names></name><name><surname>Wicinski</surname><given-names>B</given-names></name><name><surname>Santos</surname><given-names>M</given-names></name><name><surname>Schmeidler</surname><given-names>J</given-names></name><name><surname>Giannakopoulos</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Decreased pyramidal neuron size in Brodmann areas 44 and 45 in patients with autism</article-title>. <source>Acta Neuropathol</source> (<year>2012</year>) <volume>124</volume>(<issue>1</issue>):<fpage>67</fpage>&#x2013;<lpage>79</lpage>.<pub-id pub-id-type="doi">10.1007/s00401-012-0976-6</pub-id><pub-id pub-id-type="pmid">22467063</pub-id></mixed-citation>
      </ref>
      <ref id="B79">
        <label>79</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Depino</surname><given-names>AM</given-names></name><name><surname>Lucchina</surname><given-names>L</given-names></name><name><surname>Pitossi</surname><given-names>F</given-names></name></person-group>
<article-title>Early and adult hippocampal TGF-beta1 overexpression have opposite effects on behavior</article-title>. <source>Brain Behav Immun</source> (<year>2011</year>) <volume>25</volume>(<issue>8</issue>):<fpage>1582</fpage>&#x2013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbi.2011.05.007</pub-id><pub-id pub-id-type="pmid">21640817</pub-id></mixed-citation>
      </ref>
      <ref id="B80">
        <label>80</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toyoda</surname><given-names>T</given-names></name><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Yamada</surname><given-names>K</given-names></name><name><surname>Thanseem</surname><given-names>I</given-names></name><name><surname>Anitha</surname><given-names>A</given-names></name><name><surname>Suda</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>SNP analyses of growth factor genes EGF, TGFbeta-1, and HGF reveal haplotypic association of EGF with autism</article-title>. <source>Biochem Biophys Res Commun</source> (<year>2007</year>) <volume>360</volume>(<issue>4</issue>):<fpage>715</fpage>&#x2013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbrc.2007.06.051</pub-id><pub-id pub-id-type="pmid">17626784</pub-id></mixed-citation>
      </ref>
      <ref id="B81">
        <label>81</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname><given-names>AJ</given-names></name></person-group>
<article-title>Decreased phosphorylated protein kinase B (Akt) in individuals with autism associated with high epidermal growth factor receptor (EGFR) and low gamma-aminobutyric acid (GABA)</article-title>. <source>Biomark Insights</source> (<year>2015</year>) <volume>10</volume>:<fpage>89</fpage>&#x2013;<lpage>94</lpage>.<pub-id pub-id-type="doi">10.4137/BMI.S21946</pub-id><pub-id pub-id-type="pmid">26508828</pub-id></mixed-citation>
      </ref>
      <ref id="B82">
        <label>82</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>E-J</given-names></name><name><surname>Ahn</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>K</given-names></name><name><surname>Mahmood</surname><given-names>U</given-names></name><name><surname>Kim</surname><given-names>H-S</given-names></name></person-group>. <article-title>Early behavioral abnormalities and perinatal alterations of PTEN/AKT pathway in valproic acid autism model mice</article-title>. <source>PLoS One</source> (<year>2016</year>) <volume>11</volume>(<issue>4</issue>):<fpage>e0153298</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0153298</pub-id><pub-id pub-id-type="pmid">27071011</pub-id></mixed-citation>
      </ref>
      <ref id="B83">
        <label>83</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname><given-names>AJ</given-names></name><name><surname>Krigsman</surname><given-names>A</given-names></name><name><surname>Jepson</surname><given-names>B</given-names></name><name><surname>Wakefield</surname><given-names>A</given-names></name></person-group>
<article-title>Decreased serum hepatocyte growth factor (HGF) in autistic children with severe gastrointestinal disease</article-title>. <source>Biomark Insights</source> (<year>2009</year>) <volume>4</volume>:<fpage>181</fpage>&#x2013;<lpage>90</lpage>.<pub-id pub-id-type="pmid">20029653</pub-id></mixed-citation>
      </ref>
      <ref id="B84">
        <label>84</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naldini</surname><given-names>L</given-names></name><name><surname>Weidner</surname><given-names>KM</given-names></name><name><surname>Vigna</surname><given-names>E</given-names></name><name><surname>Gaudino</surname><given-names>G</given-names></name><name><surname>Bardelli</surname><given-names>A</given-names></name><name><surname>Ponzetto</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor</article-title>. <source>EMBO J</source> (<year>1991</year>) <volume>10</volume>(<issue>10</issue>):<fpage>2867</fpage>&#x2013;<lpage>78</lpage>.<pub-id pub-id-type="pmid">1655405</pub-id></mixed-citation>
      </ref>
      <ref id="B85">
        <label>85</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>DB</given-names></name><name><surname>Sutcliffe</surname><given-names>JS</given-names></name><name><surname>Ebert</surname><given-names>PJ</given-names></name><name><surname>Militerni</surname><given-names>R</given-names></name><name><surname>Bravaccio</surname><given-names>C</given-names></name><name><surname>Trillo</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>A genetic variant that disrupts MET transcription is associated with autism</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2006</year>) <volume>103</volume>(<issue>45</issue>):<fpage>16834</fpage>&#x2013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0605296103</pub-id><pub-id pub-id-type="pmid">17053076</pub-id></mixed-citation>
      </ref>
      <ref id="B86">
        <label>86</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>DB</given-names></name><name><surname>D&#x2019;Oronzio</surname><given-names>R</given-names></name><name><surname>Garbett</surname><given-names>K</given-names></name><name><surname>Ebert</surname><given-names>PJ</given-names></name><name><surname>Mirnics</surname><given-names>K</given-names></name><name><surname>Levitt</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Disruption of cerebral cortex MET signaling in autism spectrum disorder</article-title>. <source>Ann Neurol</source> (<year>2007</year>) <volume>62</volume>(<issue>3</issue>):<fpage>243</fpage>&#x2013;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1002/ana.21180</pub-id><pub-id pub-id-type="pmid">17696172</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>